This content requires Adobe Flash Player 8

Click Here to Download

Programs | Part 2: The Approach to Early RA Patients

View Broadcast

Release Date: Thursday, December 3, 2009
Expiration Date: Thursday, December 2, 2010
Cost: No Charge
   

Documents for Download
 
Program Materials
Updated Satellite Technical Sheet
Part 2 Program Syllabus
Program Evaluation
CME/CE Request Form
Sign In Sheet
Program Slides

 

 

To complete the on-line evaluation and credit request form and to print your certificate, choose the appropriate link:
 
The Outcome Tool Survey is now available for "Managing Rheumatoid Arthritis in the Primary Care Setting" participants
 
Physician CME "Snack" Survey  CME Snacks are defined as continuing education activities certified/designated for less than 1.0 CME credit.

This series is provided by   

Management of rheumatoid arthritis is clearly an important and frequent concern for physicians, whose goal is to effectively manage pain, retard or eliminate radiographic progression, maintain or restore physical function, and minimize or abolish signs and symptoms and limit the side effects of therapeutic interventions.  As RA patients face substantial loss of functioning and mobility, a long-term management plan and treatment strategy should occur at a very early stage in the disease. 
 
This program will review the prevalence of RA in primary care, discuss the importance of early diagnosis and treatment, explore pharmacologic and non-pharmacologic treatment strategies, and discuss when a patient should be referred to specialist care.
 
Target Audience
This program is intended for family practitioners, general internists, advanced nurse practitioners, physician assistants and other healthcare providers.
 
Program Objectives
  • Review the role of primary care in the management of rheumatoid arthritis (RA) and its comorbidities
  • Identify the clinical characteristics of RA and the concept of pattern recognition as it applies to chronic inflammatory arthritis
  • Identify histologic, anatomic, and physiologic considerations that contribute to the pathogenesis of RA
  • Describe treatment goals and/or outcome measures for managing RA
  • Devise strategies for implementing RA therapies to maximize their safety and efficacy
  • Apply evidence and best practices to manage the complexities of RA in the primary care setting
  • Describe the systemic complications of RA and integrate the treatment of comorbidities into patients' overall treatment plan
Faculty
John J. Cush, MD
Director of Clinical Rheumatology
Baylor Research Institute
Professor of Medicine and Rheumatology
Baylor University Medical Center
Clinical Professor of Internal Medicine
University of Texas Southwestern Medical Center
Dallas, Texas
 
Robin A. Hall, DO
Private Practice
Destination Health
Southlake, Texas
Assistant Clinical Professor
Department of Family Practice
University of North Texas Health Science Center
Fort Worth, Texas
 
Release and Termination Dates
Release: Thursday, December 3, 2009
12:00 PM - 12:30 PM ET
Termination:  Thursday, December 2, 2010
 
Accreditation
Physician
The University of Texas Southwestern Medical Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
 
The University of Texas Southwestern Medical Center designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit. Physicians should only claim credit commensurate with the extent of their participation in the activity.  
 
Nursing
The Camenae Group, Inc, is an approved provider of continuing nursing education by the Texas Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.  This activity meets Type I criteria for mandatory continuing education requirements toward relicensure as established by the Board of Nursing.
 
The Camenae Group, Inc. provides up to 4.5 contact hours for successful completion of this educational activity (0.5 contact hours for each Part).
 
This activity is supported by educational donations provided by Amgen and Pfizer Inc.